Subcutaneous injection of organophosphate (Fenitrothion)-Management of preventing the appearance of toxic symptoms: A case report.
acetylcholinesterase
organophosphate
poisoning
subcutaneous injection
Journal
Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
received:
30
12
2020
revised:
23
04
2021
accepted:
11
05
2021
entrez:
16
7
2021
pubmed:
17
7
2021
medline:
17
7
2021
Statut:
epublish
Résumé
There is a risk of unnecessary extensive incision because of swelling after the subcutaneous injection; however, removing completely the injected organophosphate by making a skin incision before the appearance of toxic symptoms could reduce sequelae.
Identifiants
pubmed: 34267910
doi: 10.1002/ccr3.4424
pii: CCR34424
pmc: PMC8271260
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e04424Informations de copyright
© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Déclaration de conflit d'intérêts
None declared.
Références
J Dermatol. 2012 May;39(5):499-500
pubmed: 21967147
J Forensic Leg Med. 2008 May;15(4):256-8
pubmed: 18423360
Clin Toxicol (Phila). 2020 Apr;58(4):227-232
pubmed: 31500467
J Int Med Res. 2020 Dec;48(12):300060520977392
pubmed: 33356707
Lancet. 2008 Feb 16;371(9612):597-607
pubmed: 17706760